GlassScriptPhysician profile
Brian H Chon
NPI 1164459079
$1,769.92
in general payments reported to CMS, 2019-2025
11 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $37.59 · 2022: $1,177 · 2023: $140 · 2024: $303 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iba Proton Therapy, INC. | $1,273.00 | 2022-2024 | |
| Exelixis INC. | $128.47 | 2022 | |
| Karyopharm Therapeutics INC. | $124.99 | 2023 | Xpovio |
| Novocure INC. | $52.64 | 2020-2025 | Optune Gio |
| Palette Life Sciences, INC. | $48.98 | 2022 | |
| Teleflex LLC | $47.47 | 2025 | Barrigel |
| Telix Pharmaceuticals | $29.73 | 2024 | Illuccix |
| Bioprotect Medical, INC. | $20.74 | 2025 | Bioprotect Balloon Implant System |
| Boston Scientific Corporation | $16.14 | 2025 | Spaceoar System |
| Progenics Pharmaceuticals, INC. | $14.96 | 2023 | Pylarify |
| Allergan, INC. | $12.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Chon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.